INTERCEPT

Serial Number 99073125
661

Registration Progress

Application Filed
Mar 7, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

INTERCEPT

Basic Information

Serial Number
99073125
Filing Date
March 7, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
661
Status Date
Nov 6, 2025
Application
Pending
Classes
005

Rights Holder

Cerus Corporation

03
Address
1220 Concord Avenue
Concord, CA 94520

Ownership History

Cerus Corporation

Original Applicant
03
Concord, CA

Legal Representation

Attorney
Nate A. Garhart

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description Documents
Nov 6, 2025 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Nov 6, 2025 IUAF S USE AMENDMENT FILED Loading...
Nov 6, 2025 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Nov 6, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 6, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 6, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 5, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 5, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Nov 5, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 9, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 9, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 9, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 9, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 7, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 7, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 7, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Blood products, namely, platelets, plasma, red blood cells, cryoprecipitate and fibrinogen complex for medical purposes; pathogen inactivated blood for medical purposes; pathogen inactivated blood products, namely, platelets, plasma, red blood cells, cryoprecipitated plasma and fibrinogen complex for medical purposes; pathogen reduced blood products, namely, platelets, plasma, red blood cells, cryoprecipitate and fibrinogen complex for medical purposes.
First Use Anywhere: Dec 31, 2006
First Use in Commerce: Dec 31, 2014

Classification

International Classes
005